Leading pharmaceutical companies, such as Abbott, Pfizer, GlaxoSmithKline, Teva-SICOR Pharmaceuticals, AstraZeneca and Johnson & Johnson will deliver presentations at the conference programme.
The conference will feature a mix of case study and tutorial presentations aimed at providing industry professionals with a 360-degree view of the biopharmaceutical landscape.
This year's event also includes three keynote presentations featuring speakers from industry, FDA and a philanthropic organization to provide balanced perspective on today's most pertinent pharmaceutical issues.
The conference programme is closely aligned with new contamination control and RFID focus areas of the show to balance business and educational opportunities. It incorporates a new Contamination Control conference track as well as many PAT and RFID-related presentations to address today's most pressing biopharmaceutical issues. From talks on core manufacturing issues to the latest in preventive medicines and vaccines, conference attendees will gain insight into the multi-dimensional issues facing drug companies today.
"Today's professionals are drawn to Interphex as much for educational opportunities as for those face-to-face meetings and live demonstrations that have always been an important part of the event," said RJ Palermo, event director at Reed Exhibitions, in an official release.